Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology

Next-generation sequencing (NGS) technology is capable of sequencing millions or billions of DNA molecules simultaneously. Therefore, it represents a promising tool for the analysis of molecular targets for the initial diagnosis of disease, monitoring of disease progression, and identifying the mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuchao, Liang, Zhiyong, Wang, Shengyue, Lu, Shun, Song, Yong, Cheng, Ying, Ying, Jianming, Liu, Weiping, Hou, Yingyong, Li, Yangqiu, Liu, Yi, Hou, Jun, Liu, Xiufeng, Shao, Jianyong, Tai, Yanhong, Wang, Zheng, Fu, Li, Li, Hui, Zhou, Xiaojun, Bai, Hua, Wang, Mengzhao, Lu, You, Yang, Jinji, Zhong, Wenzhao, Zhou, Qing, Yang, Xuening, Wang, Jie, Huang, Cheng, Liu, Xiaoqing, Zhou, Xiaoyan, Zhang, Shirong, Tian, Hongxia, Chen, Yu, Ren, Ruibao, Liao, Ning, Wu, Chunyan, Zhu, Zhongzheng, Pan, Hongming, Gu, Yanhong, Wang, Liwei, Liu, Yunpeng, Zhang, Suzhan, Liu, Tianshu, Chen, Gong, Shao, Zhimin, Xu, Binghe, Zhang, Qingyuan, Xu, Ruihua, Shen, Lin, Wu, Yilong, Tumor Biomarker Committee, On behalf of Chinese Society of Clinical Oncology (CSCO)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2019
Materias:
Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528448/
https://www.ncbi.nlm.nih.gov/pubmed/31119060
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0142

Ejemplares similares

Ejemplares similares